...
首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Cooperating gene mutations in childhood acute myeloid leukemia with special reference on mutations of ASXL1, TET2, IDH1, IDH2, and DNMT3A.
【24h】

Cooperating gene mutations in childhood acute myeloid leukemia with special reference on mutations of ASXL1, TET2, IDH1, IDH2, and DNMT3A.

机译:儿童急性髓性白血病中的合作基因突变,特别涉及ASXL1,TET2,IDH1,IDH2和DNMT3A的突变。

获取原文
获取原文并翻译 | 示例

摘要

Gene mutations involving epigenetic regulators recently have been described in adult acute myeloid leukemia (AML). Similar studies are limited in children. We analyzed gene mutations and cooperation in pediatric AML with special reference on mutated epigenetic regulators. Nineteen gene mutations, including 8 class I genes, 4 class II genes, WT1 and TP53 (class III), and 5 epigenetic regulator genes (class IV), were analyzed in 206 children with de novo AML. Mutational analysis was performed with polymerase chain reaction-based assay followed by direct sequencing. One hundred seventeen of 206 patients (56.8%) had at least one mutation: 51% class I, 13% class II, 6.8% class III, and 5.6% class IV. FLT3-internal tandem duplication was most frequent, and 29% of patients had more than one gene mutation. Two patients carried ASXL1 mutations, both with t(8;21), 2 had DNMT3A mutations, 2 had IDH1 mutations, 1 had IDH2 mutation, and 3 had TET2 mutations. Both patients with IDH1 mutations had AML-M0 subtype and MLL-partial tandem duplication. Cooperating mutations with mutated epigenetic regulators were observed in 8 of 10 patients. We conclude that mutated epigenetic regulators were much less than those in adult AML but with frequent cooperating mutations. ASXL1, TET2, and IDH1 mutations were associated with specific genetic subtypes.
机译:成人急性髓细胞性白血病(AML)中最近描述了涉及表观遗传调控因子的基因突变。类似的研究仅限于儿童。我们分析了儿科AML中的基因突变和合作,特别是对表观遗传调控子的突变。在206例从头AML患儿中分析了19个基因突变,包括8个I类基因,4个II类基因,WT1和TP53(III类)和5个表观遗传调控基因(IV类)。使用基于聚合酶链反应的分析进行突变分析,然后进行直接测序。 206名患者中的一百一十七名(56.8%)至少具有一种突变:I级为51%,II级为13%,III级为6.8%和IV级为5.6%。 FLT3内部串联重复最为频繁,并且29%的患者具有一个以上的基因突变。 2例患者携带ASXL1突变,均具有t(8; 21),2例患者具有DNMT3A突变,2例患者具有IDH1突变,1例患者具有IDH2突变,3例患者具有TET2突变。两名IDH1突变患者均患有AML-M0亚型和MLL部分串联重复。在10位患者中有8位观察到与突变的表观遗传调控因子协同突变。我们得出的结论是,表观遗传调控子比成人AML少得多,但具有频繁合作的突变。 ASXL1,TET2和IDH1突变与特定的遗传亚型相关。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号